Ahzantive (aflibercept-mrbb) - Amneal, Formycon, Coherus Biosci, Klinge Pharma, Teva
Cimerli (ranibizumab-eqrn) - Amneal, Formycon, Coherus Biosci, Teva
Otulfi (ustekinumab-aauz) - Formycon, Fresenius Kabi
https://www.formycon.com/en/blog/press-release/formycon-reports-on-a-successful-financial-year-2024-with-strong-operational-progress-and-continuous-strengthening-of-its-market-position/
 
Mar 27, 2025
 
Prev Next